2011-08-04 Assigned to MUSCULOSKELETAL TRANSPLANT FOUNDATION reassignment
MUSCULOSKELETAL TRANSPLANT FOUNDATION ASSIGNMENT OF ASSIGNORS …

US7413734B2 - Treatment of retinitis pigmentosa with human umbilical cord cells - Google
Patents US7413734B2 - Treatment of retinitis pigmentosa with human umbilical cord cells …

The present invention provides compositions and methods of using embryonic-like stem
cells that originate from a post-partum placenta with conventional cord blood compo sitions …

(57) ABSTRACT A method of manufacturing a tissue matrix for implantation into a patient is
disclosed. The method sets forth collecting embryonic stem cells from a placenta Which has …

5,589,376 A 12/1996 Anderson et a1......... 435/240.2 5,670,483 A* 9/1997 zhang et
31'""""""""" 514/14 Cells derivedfromhumanumbilical cords are disclosedalong 5,677,181 A …

2004-12-16 Assigned to ETHICON, INCORPORATED reassignment ETHICON,
INCORPORATED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …

4,882,162 A 11, 1989 Ikada et al......... 424/444 placebo-controlled, clinical trial of high-dose
Supplementation with 4,963,489 A 10/1990 Naughton et al. 435.240. 1 vitamins C and E …

US20060153815A1 - Tissue engineering devices for the repair and regeneration of tissue -
Google Patents US20060153815A1 - Tissue engineering devices for the repair and regeneration …

5,811,094. A 9/1998 Caplanet al...... 424/93.7 tum tissue-derived cells, are provided by the
invention. The 5,827,735 A 10/1998 Young et al................. 435/325 invention also provides …

Methods for promoting angiogenesis comprising administer ing platelet-rich plasma to a site
and stimulating the site with an electromagnetic field. Platelets include platelet-rich plasma …